In addition, functional cooperation of miR-125a, miR-125b, and miR-205 can act together to suppress erbB2/erbB3 expression in breast cancer cells, which manifest a novel breast cancer treatment via miRNA-dependent or -independent mechanisms [81]. This evidence concerns the gene ERBB2 and breast carcinoma.